Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
08:30am, Wednesday, 03'rd Feb 2021
SOUTH SAN FRANCISCO, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines administered by tablet, today announced pr
VXRT Stock Alert: 2 Things for Vaxart Investors to Know as Shares Pop Today
11:50am, Tuesday, 02'nd Feb 2021
Vaxart (VXRT) stock is heading higher Tuesday and there are a couple of things investors will want to keep in mind about the biotech company. The post VXRT Stock Alert: 2 Things for Vaxart Investors t
Vaxart, Macy's, Gogo: Will These Stocks See A GameStop Like Short Squeeze?
09:00am, Tuesday, 02'nd Feb 2021
The GameStop short-squeeze saga has turned the spotlight on small and mid-cap stocks with a high level of short interest. Heavily shorted stocks could be targeted for so-called social trades by retail
VXRT Stock Price Increases Over 25%: Why It Happened
02:21pm, Monday, 01'st Feb 2021
The stock price of Vaxart Inc (NASDAQ: VXRT) is trading at over 25% today. This is why it happened.
Week 5 MDA Breakout Stocks - February 2021: Short-Term Picks To Give You An Edge
04:16am, Monday, 01'st Feb 2021
Two new breakout stocks for Week 5 of 2021 with better than 10% short-term upside potential. This past week all 4 stocks gained over 10% with NBSE and QDEL gaining over 20% before pulling back on Frid
Biden's Latest Move Just Handed the Vaccine Market to These 2 Companies
06:55am, Saturday, 30'th Jan 2021
They can't vaccinate the whole world against COVID-19 -- but they may vaccinate all of the U.S.
Is Vaxart Stock a Buy?
06:15am, Saturday, 30'th Jan 2021
A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed?
NEW YORK--(BUSINESS WIRE)-- #Investigation--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Vaxart, Inc. (NASDAQ: VXRT) on b
Glancy Prongay & Murray LLP Announces Investigation of Vaxart, Inc.
04:04pm, Wednesday, 27'th Jan 2021
NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Vaxart, Inc. (NASDAQ: VXRT) concerning the Company and its directors' and officers' possible violation
Is Vaxart Stock A Buy Ahead Of Phase 1 Data Readout?
10:00am, Wednesday, 27'th Jan 2021
Biotech company Vaxart's stock has rallied by about 40% over the last 5 trading days, with a bulk of the gains coming on Monday. The stock is also up by about 76% since the beginning of 2021, compared
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine
08:30am, Wednesday, 27'th Jan 2021
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data and Publication
08:30am, Tuesday, 26'th Jan 2021
New pre-clinical histology data show that Vaxart's oral vaccine protected against lung inflammation in hamster models
Is Vaxart Stock Worth The Risk?
08:30am, Monday, 25'th Jan 2021
Biotech company Vaxart stock is up by over 11x through the last 12 months rising to levels of around $7 per share, driven by the company's efforts to develop a Covid-19 vaccine. Vaxart, which focuses
3 Stocks That Could Realistically Triple Your Money in 2021
06:09am, Friday, 22'nd Jan 2021
No kidding around ... here's how they truly can.
The 17 Stocks That Outperformed Tesla In 2020
11:54am, Thursday, 21'st Jan 2021
This article looks at the 17 companies listed on U.S. exchanges that had a higher total return than high-flying Tesla in 2020. The stocks tended to be microcap to small cap stocks in sectors that piqu
